H.C. Wainwright analyst Raghuram Selvaraju adjusted the firm’s price target on Assertio (ASRT) to $35 from $3 and keeps a Buy rating on the shares ...

Assertio Holdings (ASRT) will implement a one-for-fifteen reverse split of its issued and outstanding common stock, the company said on Monday. The reverse split will become effective as of 12:01 a.m.

Assertio Holdings showed Q1 2023 net product sales increase of 18%, despite reporting a net loss due to increased expenses. Assertio's growth strategy involves expanding product range through ...

LAKE FOREST, Ill., May 12, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio” or the "Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering ...

Company Will Report Third Quarter Results on November 10, 2025 and Expects to Update Guidance Within the Current Range at That Time LAKE FOREST, Ill., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Assertio ...

As of Friday, December 26, Assertio Holdings, Inc.’s ASRT share price has surged by 1400.23%, which has investors questioning if this is right time to sell.

LAKE FOREST, Ill., April 22, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release first quarter 2022 financial results on ...

Assertio Holdings ASRT is soon to report third-quarter 2022 results. In the third-quarter 2022 results, we expect investors to focus on the sales performance of Assertio’s marketed drugs and the ...

Assertio Holdings has dropped substantially and is down more than 70% in the past year. Assertio Holdings appears to have been oversold based on quantitative factors. It trades at a very low ...

ASSERTIO THERAPEUTICS ($ASRT) posted quarterly earnings results on Wednesday, March 12th. The company reported earnings of -$0.11 per share, missing estimates of -$0. ...

Note Regarding Use of Non-GAAP Financial MeasuresAssertio and Zyla provide non-GAAP adjusted EBITDA margin, or earnings before interest, taxes, depreciation and amortization margin, as a financial ...

Appoints Industry Veteran and Current Director Mark L. Reisenauer as CEO, Effective Immediately Company Will Report Third Quarter Results on November 10, 2025 and Expects to Update Guidance Within the ...